๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer Enterostomy
NCT07172087Colorectal Cancer
Sichuan Cancer Hospital and Research Institute
Not applicable
258
Chengdu
2025-09
Not yet open
A Study of Sacituzumab Govitecan Plus Toripalimab Versus Toripalimab Plus Nab-Paclitaxel in PD-L1 Positive Advanced TNBC
NCT07040644Triple Negative Breast Neoplasms
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
150
Guangzhou
2025-09
Not yet open
Study on Proteomic and Microbiome Changes in Patients With Hepatic Encephalopathy (HE)
NCT07150195Cirrhoses, Liver, Hepatic Encephalopathy (HE)
The First Affiliated Hospital with Nanjing Medical University
Observational
32
Nanjing
2025-09
Not yet open
Study of CM313 in Subject With IgA Nephropathy
NCT06830395IgA Nephropathy
Keymed Biosciences Co.Ltd
Phase 2
106
Beijing
2025-09
Not yet open
Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients
NCT07181239Multiple Myeloma (MM)
Keymed Biosciences Co.Ltd
Phase 3
280
Tianjin
2025-09
Not yet open
Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological Malignancies
NCT07110194CD20-positive Hematological Malignancies
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Phase 1
75
Beijing
2025-09
Recruiting
An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases
NCT07174843Idiopathic Inflammatory Myopathies(IIM), Immune Thrombocytopenia(ITP), Systemic Lupus Erythematosus(SLE)
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1
20
Shanghai
2025-09
Not yet open
The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
NCT07139587Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Qingxia Li
Not applicable
30
Shijiazhuang
2025-09
Not yet open
Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier Granules
NCT05871437Breast Cancer
Fudan University
Phase 4
232
Shanghai
2025-09
Recruiting
Study of CM559 in Healthy Subjects
NCT07175506Healthy Subjects
Keymed Biosciences Co.Ltd
Phase 1
40
Chengdu
2025-09
Not yet open
T-DXd With or Without Bevacizumab for HER2-low Breast Cancer With Brain Metastasis
NCT07150208Breast Cancer With Brain Metastasis, HER2-low Expressing Breast Cancer
Fudan University
Phase 2
140
Shanghai
2025-09
Not yet open
Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer
NCT07088731Cervical Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
180
Beijing
2025-09
Recruiting
Comparative Study of New Classification and Traditional Classification of Radioactive Oropharyngeal Mucositis
NCT06307327Head and Neck Cancer, Radiation-Induced Mucositis
Nanfang Hospital, Southern Medical University
Observational
264
Guangzhou, Huizhou, Jieyang, Meizhou
2025-09
Not yet open
Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy
NCT07192848Hepatocellular Carcinoma Non-resectable
Song Peng
Phase 2
47
Shenzhen
2025-09
Not yet open
Low Powered Colorectal Anastomosis After Rectal Excision (OASIS)
NCT07146334Rectal Cancer, Surgery Indication
Bordeaux Colorectal Institute
Observational
400
Shanghai
2025-09
Not yet open
A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid Tumors
NCT07185893Solid Tumor Malignancies, Cancer, CTIT-Chemotherapy Induced Thrombocytopenia, Thrombocytopenia
Jun wang
Not applicable
106
Shijiazhuang
2025-09
Not yet open
Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy
NCT05576766Prostate Cancer, Robot-Assisted Laparoscopic Radical Prostatectomy, Enhanced Recovery After Surgery (ERAS) Protocol, Prehabilitation
Peking University First Hospital
Not applicable
54
Beijing
2025-09
Not yet open
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
NCT07142837Advanced Solid Tumor
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
153
Beijing
2025-09
Not yet open
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary Disease
NCT07147946Chronic Obstructive Pulmonary Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
666
Bozhou, Chizhou, Hefei, Chongqing, Fuzhou, Zhangzhou, Lanzhou, Foshan
2025-09
Not yet open
Cabozantinib for Progressive HCC Post-first-line Immuno-oncologic Combination Therapy
NCT07151326Hepatocellular Carcinoma (HCC)
National Health Research Institutes, Taiwan
Phase 2
60
2025-09
Recruiting
The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )
NCT07140237Healthy Adult Male
University of Electronic Science and Technology of China
Phase EARLY_PHASE1
250
Chengdu
2025-09
Recruiting
Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
NCT07181499NSCLC, Adjuvant Drug Therapy, EGFR
Betta Pharmaceuticals Co., Ltd.
Phase 2
28
Guangzhou, Zhuhai
2025-09
Not yet open
Brentuximab Vedotin Combined With R-CHP in Newly Diagnosed EBV+ DLBCL-NOS
NCT06925555EBV-Positive Diffuse Large B-Cell Lymphoma, Nos, Brentuximab Vedotin
The First Affiliated Hospital with Nanjing Medical University
Phase 2
25
Nanjing
2025-09
Not yet open
A Phase I Trial of QLS1410 in Healthy Chinese Adults and Participants With Mild Essential Hypertension
NCT07152444Uncontrolled Hypertension
Qilu Pharmaceutical Co., Ltd.
Phase 1
78
Beijing
2025-09
Not yet open
A Phase 2 Study of TRS005 in Patients With CD20-positive R/R DLBCL.
NCT06886139CD20-positive Diffuse Large B-Cell Lymphoma
Zhejiang Teruisi Pharmaceutical Inc.
Phase 2
139
Beijing
2025-09
Not yet open
A Study of Stapokibatrt in Children Subjects With Atopic Dermatitis
NCT07106372Atopic Dermatitis
Keymed Biosciences Co.Ltd
Phase 3
240
Beijing
2025-09
Recruiting
Standard Second-line Therapy With ONgericimab and TOripalimab in pMMR/MSS Colorectal Cancer: a Single-arm Phase II Trial
NCT07106034Advanced Colorectal Cancer
Shanghai Pudong Hospital
Phase 2
32
Shanghai
2025-08-31
Recruiting
Risk Factors, Prognosis, Clinicopathological and Metabolic Characteristics of EO- vs LO-PanNETs
NCT07136701Pancreatic Neuroendocine Neoplasms (pNETs)
Qilu Hospital of Shandong University
Observational
600
Jinan
2025-08-31
Not yet open
Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC
NCT07116577mCRC
Jinan Central Hospital
Phase 2
37
Jinan
2025-08-31
Not yet open
A Clinical Study on the Use of a Domestically Produced Cryoablation System Combined With Balloon Cryoablation Technology for the Treatment of Paroxysmal Atrial Fibrillation
NCT07036068Paroxysmal Atrial Fibrillation (PAF)
Shanghai MicroPort EP MedTech Co., Ltd.
Not applicable
20
Chengdu
2025-08-31
Not yet open
Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency
NCT07126288Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD), Growth Hormone
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase 2/3
268
Xiamen, Nanyang, Xinxiang, Wuhan, Suzhou, Nanchang, Pingxiang, Changchun
2025-08-31
Not yet open
A Study of IBI363 Combination Therapy in Participants With Advanced Solid Tumors
NCT07124793EGFR Mutant NSCLC and Platinum Resistant Ovarian Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
60
Wuhan
2025-08-31
Recruiting
High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy
NCT07159022High Flow Nasal Cannula, Body Roundness Index
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2025-08-31
Recruiting
Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
NCT07132684AML, Adult
Institute of Hematology & Blood Diseases Hospital, China
Phase 3
240
Tianjin
2025-08-31
Recruiting
INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)
NCT07089862Unruptured Intracranial Aneurysm, Indobufen
Beijing Tiantan Hospital
Not applicable
2,500
Beijing
2025-08-31
Not yet open
Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Stroke
NCT05155358Heat Stroke, Early Waking, MODS, Proteinosis
Xijing Hospital
Observational
150
Xi'an
2025-08-31
Not yet open
Menstrual Blood-Derived Mesenchymal Stem Cell Injection (SC01009) in the Treatment of Idiopathic Pulmonary Fibrosis
NCT07131150Idiopathic Pulmonary Fibrosis (IPF)
Ruijin Hospital
Phase 2
66
Beijing, Guangzhou, Shenzhen, Hebei, Zhengzhou, Wuhan, Changsha, Nanjing
2025-08-31
Recruiting
The Diagnostic Value of Subharmonic Imaging Technology Combined With Liver Stiffness and Platelet Count for High-risk Esophageal and Gastric Varices in Patients With Liver Cirrhosis
NCT07151885Liver Cirrhosis, Esophageal and Gastric Varices
The First Hospital of Jilin University
Not applicable
380
Changchun
2025-08-31
Not yet open
A Study of GR1803 Injection in Combination With Anti-CD38 Monoclonal Antibody for the Treatment of Participants With Multiple Myeloma
NCT07090954Multiple Myeloma
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 1/2
32
Shanghai, Xi'an
2025-08-31
Not yet open
Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis
NCT07054736Atopic Dermatitis
Zhejiang Kanova Biopharmaceutical Co., LTD
Phase 2
120
Hangzhou
2025-08-31
Not yet open
A Study of RAY1225 Versus Semaglutide as Add-on Therapy to Oral Antidiabetic Drugs in Participants With Type 2 Diabetes
NCT07139548T2DM
Guangdong Raynovent Biotech Co., Ltd
Phase 3
600
Beijing
2025-08-31
Not yet open
Early Blood Pressure Intervention After Coiling or Clipping for Subarachnoid Hemorrhage
NCT07149922Aneurysmal Subarachnoid Hemorrhage, Aneurysmal Subarachnoid Hemorrhage (aSAH)
Beijing Tiantan Hospital
Not applicable
750
Beijing
2025-08-31
By invitation
Diagnostic Application of AI-ROSE in Severe Pneumonia
NCT07113951Severe Pneumonia, Bacterial Infections
The First Affiliated Hospital with Nanjing Medical University
Observational
100
Nanjing
2025-08-31
Recruiting
Efficacy of a Health Empowerment Theory Based Health Information Literacy Promotion Intervention in Individuals With Metabolic Syndrome
NCT07096102Metabolic Syndrome (MetS)
Meihua Ji
Not applicable
310
Beijing
2025-08-31
Not yet open
A Study of RAY1225 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
NCT07139535T2DM
Guangdong Raynovent Biotech Co., Ltd
Phase 3
350
Beijingcun
2025-08-31
Recruiting
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
NCT07100600HER2-positive Advanced Breast Cancer, Brain Metastases, Radiotherapy
Henan Cancer Hospital
Phase 2
224
Zhengzhou
2025-08-30
Not yet open
HS-IT101 Injection for Advanced NSCLC
NCT07105176Advanced Non-Small Cell Lung Cancer
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase 1
12
Guangzhou
2025-08-30
Not yet open
QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD)
NCT07113964Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency
The First Affiliated Hospital with Nanjing Medical University
Phase 2
79
Nanjing
2025-08-30
Recruiting
Tirofiban With Sequential Dual Antiplatelet Therapy in Mild Stroke
NCT07095790Mild Stroke
Second Affiliated Hospital of Soochow University
Phase 4
580
Suzhou, Shijiazhuang, Zhoukou, Bayan Nur, Huai'an, Suqian, Taizhou, Xi'an
2025-08-30
Not yet open
Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer
NCT07159217Biliary Tract Cancer, Disitamab Vedotin, Lenvatinib, Immune Checkpoint Inhibitors
Peking Union Medical College Hospital
Phase 2
65
Beijing
2025-08-30
Recruiting
Compression Stockings to Prevent Peripheral Neuropathy Caused by Antibody-Drug Conjugates in Urothelial Carcinoma Patients
NCT07164950Urothelial Carcinoma, Advanced Solid Tumors, Chemotherapy-Induced Peripheral Neuropathy, Antibody-drug Conjugates
Sheng Zhang
Not applicable
58
Shanghai
2025-08-30
Not yet open
Efficacy of Methylene Blue Plus Ropivacaine for Post-Hemorrhoidectomy Pain.
NCT07164807Mixed Hemorrhoids, Milligan-Morgan Hemorrhoidectomy, Methylene Blue
The Affiliated Hospital of Putian University
Phase 4
177
Putian
2025-08-30
Recruiting
Baduanjin With Resistance Training Program
NCT06853132Osteoporosis, Lumbar Disc Herniation
Yale University
Not applicable
110
Changsha
2025-08-30
Recruiting
Node-Sparing Hypofractionated Radiotherapy Plus Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advanced Colon Cancer: A Prospective, Randomized, Phase II Trial
NCT07230639Neoadjuvant Therapies, Immune Checkpoint Therapy, Radiotherapy
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
52
Guangzhou
2025-08-30
Recruiting
Pulmonary Microbiota Changes and Clinical Outcomes in Neurosurgical ICU Patients With Artificial Airways
NCT07129174Ventilator-Associated Pneumonia (VAP), Intensive Care Unit (ICU) Patients, Microbiome Dysbiosis
Jian-Xin Zhou
Observational
220
Beijing
2025-08-30
Recruiting
Development and Validation of Delirium Recognition Using Computer Vision in Neuro-critical Patients
NCT07136207Delirium, Artificial Intelligence (AI)
Beijing Tiantan Hospital
Observational
1,000
Beijing
2025-08-30
Not yet open
Impact of Delayed Cord Clamping and Minimally Invasive Surfactant Administration on Outcomes in Premature Infants Less Than 30 Weeks Gestation
NCT07092319NRDS
Peking University Third Hospital
Observational
518
Beijing
2025-08-30
Recruiting
Precise Guidance of Adaptive Radiotherapy for Nasopharyngeal Carcinoma
NCT07137052Nasopharyngeal Carcinoma (NPC), PET / CT
The First Affiliated Hospital of Xiamen University
Observational
732
Xiamen
2025-08-30
Not yet open
A Placebo-controlled Trial of Fractional Flow Reserve-guided Percutaneous Renal Artery Stenting Among Atherosclerosis Renal-vascular Hypertension Patients
NCT07111442Renal Artery Stenosis Atherosclerotic, Secondary Hypertension Renal Arterial
Peking University First Hospital
Not applicable
200
Beijing
2025-08-30
Recruiting
Compassion-Based Family Intervention for Adolescents
NCT07138417Emotional Disorder
Beijing HuiLongGuan Hospital
Not applicable
60
Hefei
2025-08-30
Active, closed
Therapeutic Value of Sirolimus in Refractory Adult-Onset Still's Disease
NCT07151157Adult-Onset Still's Disease
Ruijin Hospital
Not applicable
3
Shanghai
2025-08-30
Recruiting
A Clinical Study of Ultra-transplantation for the Treatment of Major Thalassemia Scheme
NCT06743477Stem Cell Transplantation
Hu Peng
Not applicable
5
Kunming
2025-08-29
Recruiting
Anlotinib Plus Whole-Brain Radiotherapy for Brain Metastases in SCLC Patients.
NCT07443397Whole-Brain Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
134
Beijing
2025-08-29
Recruiting
Safety and Efficacy of Metabolically Armed Tumor-lnfiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
NCT07106814Advanced Solid Tumors
Anhui Provincial Hospital
Phase EARLY_PHASE1
36
Hefei
2025-08-29
Recruiting
A Study of SKB518 in Patients With Lung Cancer
NCT07019675Lung Carcinoma
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
192
Shenzhen, Nanning, Zhengzhou, Wuhan, Xiangyang, Changsha, Nanchang, Jinan
2025-08-29
Recruiting
A Study to Evaluate Efficacy and Safety of LNK01001 in Adults With Ankylosing Spondylitis
NCT07237568Ankylosing Spondylitis
Lynk Pharmaceuticals Co., Ltd
Phase 3
352
Beijing
2025-08-29
Recruiting
Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
NCT07066826Alzheimer Dementia
Wanbangde Pharmaceutical Group Co., LTD
Phase 2/3
720
Beijing
2025-08-29
Recruiting
Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors
NCT07165886Gastroenteropancreatic Neuroendocrine Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 2/3
298
Beijing
2025-08-29
Recruiting
The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients
NCT07138755NSCLC, Sintilimab, Adaptive Radiotherapy
The Third Xiangya Hospital of Central South University
Phase 2
35
Changsha, Hengyang, Jishou
2025-08-29
Recruiting
The Study is Being Conducted to Evaluate the Efficacy and Safety of Dexmedetomidine Hydrochloride Microneedles for Preoperative Sedation in Children
NCT07168720Preoperative Sedation
Guangzhou Novaken Pharm Co., Ltd.
Phase 2
64
Guangzhou
2025-08-29
Recruiting
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
NCT06960213Hereditary Angioedema, HAE, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2
ADARx Pharmaceuticals, Inc.
Phase 3
90
Beijing, Harbin, Zhengzhou
2025-08-28
Recruiting
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06841679Gastric or Gastroesophageal Junction Adenocarcinoma
Beijing Biostar Pharmaceuticals Co., Ltd.
Phase 2/3
778
Anyang, Guangzhou, Jinan, Shenyang, Taiyuan, Tianjin, Wuhan, Zhengzhou
2025-08-28
Recruiting
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BSY001 After Single/Multiple Doses.
NCT07377175Smallpox, Cowpox, Monkeypox, Poxvirus Infection
China National Biotec Group Company Limited
Phase 1
76
Hangzhou
2025-08-28
Recruiting
A Study of LM-350 in Subjects With Advanced Solid Tumours
NCT07112222Malignant Tumors
LaNova Medicines Limited
Phase 1/2
80
Beijing
2025-08-28
Recruiting
Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)
NCT07110090Thrombocytopenia, Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
16
Beijing
2025-08-28
Active, closed
Adverse Events Among Hospitalized Patients in China
NCT07705204Adverse Event
Peking Union Medical College Hospital
Observational
2,807
Beijing
2025-08-28
Recruiting
A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors
NCT07123129Advanced Malignancy
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
200
Beijing, Hangzhou
2025-08-28
Recruiting
Continuous or Intermittent Pyrotinib for HER2-positive Advanced Breast Cancer
NCT07180082Advanced Breast Cancer
Wenjin Yin
Phase 2
186
Shanghai
2025-08-28
Recruiting
Prospective Pathology Foundation Models
NCT07157618Pancancer
Nanfang Hospital, Southern Medical University
Observational
2,000
Guangzhou, Jinan
2025-08-28
Recruiting
A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT07283796NHL
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
110
Tianjin
2025-08-28
Recruiting
A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer
NCT07110571Gastric Cancer, Gastroesophageal-junction Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 2
200
Shijiazhuang, Hangzhou
2025-08-28
Recruiting
Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
NCT07146100Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Observational
200
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Foshan, Guangzhou
2025-08-28
Recruiting
Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps
NCT07132827Chronic Rhinosinusitis With Nasal Polyps
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 3
280
Shanghai
2025-08-28
Recruiting
Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)
NCT07150949Locally Advanced Rectal Cancer, Neoadjuvant Therapy
Fudan University
Phase 2
138
Shanghai
2025-08-28
Recruiting
Adjuvant CDK4/6 Inhibitor Use in HR+/HER2- Breast Cancer
NCT07180056Breast Cancer
Wenjin Yin
Observational
229
Shanghai
2025-08-28
Recruiting
Trastuzumab Deruxtecan in Advanced Breast Cancer
NCT07180264Advanced Breast Cancer
Wenjin Yin
Observational
118
Shanghai
2025-08-28
Recruiting
PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)
NCT07106970Persistent Atrial Fibrillation
Boston Scientific Corporation
Not applicable
640
Beijing
2025-08-28
Not yet open
A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever
NCT07126171Chikungunya Fever
Jiangsu Kanion Pharmaceutical Co., Ltd
Not applicable
400
Guangzhou
2025-08-28
By invitation
Testing the Performance of Smartphones and Their Accessories in Detecting Irregularly Irregular Heart Rhythm
NCT07154303Atrial Fibrillation (AF)
The University of Hong Kong
Observational
209
Hong Kong
2025-08-27
Recruiting
Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty๏ผˆTKA๏ผ‰
NCT07127042Total Knee Arthroplasty
ScinnoHub Pharmaceutical Co., Ltd.
Phase 2
270
Chengdu
2025-08-27
Recruiting
A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS
NCT07084012Acute Ischemic Stroke AIS
Shenzhen Wingor Biotechnology Co., Ltd.
Phase 2
60
Beijing
2025-08-27
Recruiting
3D1015 Injection for Patients With mCRPC
NCT07537010Metastatic Castration-resistant Prostate Cancer, mCRPC
Chunjing Yu
Phase 1
8
Wuxi
2025-08-27
Recruiting
Golidocitinib Combined With Mitoxantrone Hydrochloride Liposome or Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma
NCT07093710Peripheral T Cell Lymphoma
Sun Yat-sen University
Phase 1/2
101
Guangzhou
2025-08-27
Recruiting
Electroacupuncture and rTMS for Post-Stroke Motor Recovery
NCT07113990Stroke
Jing Tao
Not applicable
180
Fuzhou, Wenzhou
2025-08-27
Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
NCT07043400Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
BeOne Medicines
Phase 3
351
Hefei, Beijing, Xiamen, Anyang, Zhengzhou, Nanjing, Ganzhou, Shenyang
2025-08-27
Recruiting
A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors
NCT07147348Advanced Solid Tumor
BioNTech SE
Phase 1/2
375
Beijing, Hefei, Henan, Hunan, Shandong, Shanghai, Sichuan, Zhejiang
2025-08-27
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
NCT07145229Acute Gouty Arthritis, Gout Flare, Gout Flares, Acute Gout Flare
Atom Therapeutics Co., Ltd
Phase 2
380
Beijing, Nanning, Langfang, Wuhan, Xiangtan, Zhuzhou, Huai'an, Pingxiang
2025-08-26
Recruiting
A Study of PEP08 in Patients With MTAP-Del Advanced or Metastatic Solid Tumors
NCT06973863Advanced Solid Tumor, Solid Tumors, MTAP-deleted Solid Tumors, MTAP Deletion
PharmaEngine
Phase 1
40
2025-08-26
Recruiting
Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors
NCT07156253Metastatic Solid Tumor, Ovarian Cancer, Breast Cancer, BRCA 1 /2 and / or HRD
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd
Phase 1
110
Shanghai
2025-08-26
Not yet open
To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery
NCT07121023Postoperative Analgesia After Unilateral Hallux Valgus Correction Surgery
Beijing Tide Pharmaceutical Co., Ltd
Phase 1
32
Beijing
2025-08-26
Rows per page Showing 6401–6500 of 19052
Previous 63 64 65 66 67 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=65

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.